Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’), Gian Life Care has informed that the Board of Directors at their meeting held on Monday, December 06, 2021, has approved incorporation/ formation of Wholly Owned Subsidiary Company to undertake the business of acquiring and running pathological labs and laboratories across the Country. The said proposal is expected to help the Company in covering new areas across all States and in turn would strengthen the financial position of the Parent Company. Details as required under Regulation 30 read with Schedule III of the Listing Regulations and the SEBI Circular CIR/CFD/CMD/4/2015 dated 9 September 2015 are attached as Annexure A to this letter.
The above information is a part of company’s filings submitted to BSE.
